Quale sarebbe il prezzo per BetterLife Pharma Inc. (BETR)

Il prezzo per BetterLife Pharma Inc. (BETR) è $0.25687791

Qual è la capitalizzazione di mercato per BetterLife Pharma Inc. (BETR)

La capitalizzazione di mercato per BetterLife Pharma Inc. (BETR) è $41.59M

BetterLife Pharma Inc. (BETR) Prezzo e Capitalizzazione di Mercato

BetterLife Pharma Inc. is a biotechnology company focused on the global development and commercialization of therapeutic compounds, particularly for neurological disorders. The firm also innovates drug candidates utilizing complementary interferon-based technologies, designed to engage the immune system in combating viral infections. Its active development pipeline includes BETR-001, intended for major depressive disorder, treatment-resistant depression, cluster headaches, and post-traumatic stress disorder. Another key asset, BETR-002, is being advanced to address benzodiazepine dependency, anxiety, and spasticity. Further in development are MM-003 for COVID-19 and other respiratory viral infections; MM-001, a topical intravaginal cream for HPV-induced cervical intraepithelial neoplasia; and AP-002, designated for cancer treatment. BetterLife Pharma Inc. maintains a research collaboration with the University of California San Diego, focusing on preclinical behavioral pharmacology studies of TD-0148A, a lysergic acid diethylamide derivative solution. Headquartered in Vancouver, Canada, the company was founded in 2002 and was formerly known as Pivot Pharmaceuticals Inc. before adopting the name BetterLife Pharma Inc. in December 2019.

Il prezzo per BETR	Attivo B	Capitalizzazione del mercato a B	Risultati
$32,322.44 $41.59M	NVDA	$5.233T	+12,582,703.00%
$28,670.31 $41.59M	AAPL	$4.641T	+11,160,965.53%
$25,283.53 $41.59M	GOOG	$4.093T	+9,842,526.38%
$22,062.85 $41.59M	MSFT	$3.572T	+8,588,747.93%
$17,364.91 $41.59M	AMZN	$2.811T	+6,759,883.91%

Il prezzo per BETR

Attivo B

Capitalizzazione del mercato a B

Risultati

$32,322.44 $41.59M